Clinical Trial Assessing Godex Carnitine Orotate Complex in Nonalcoholic Fatty Liver Disease Patients for Efficacy
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:December 1, 2023Enrolling by invitation
Hide Studies Not Open or Pending
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:December 1, 2023Enrolling by invitation
Condition(s):Hepatitis C Virus InfectionLast Updated:July 17, 2023Recruiting
Condition(s):HIV Infections; Fatty Liver DiseaseLast Updated:January 23, 2024Active, not recruiting
Condition(s):Primary Sclerosing CholangitisLast Updated:November 29, 2023Terminated
Condition(s):Non-alcoholic Steatohepatitis (NASH)Last Updated:September 5, 2021Terminated
Condition(s):Hepatitis CLast Updated:April 18, 2018Unknown status
Condition(s):Liver CirrhosisLast Updated:January 8, 2024Recruiting
Condition(s):Liver Fibrosis; Positron Emission TomographyLast Updated:September 3, 2020Unknown status
Condition(s):Alcoholic Liver CirrhosisLast Updated:December 10, 2012Unknown status
Condition(s):Hepatitis C; Drug Abuse, IntravenousLast Updated:April 10, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.